BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18540634)

  • 1. Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus S2-HR2.
    McReynolds S; Jiang S; Guo Y; Celigoy J; Schar C; Rong L; Caffrey M
    Biochemistry; 2008 Jul; 47(26):6802-8. PubMed ID: 18540634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
    Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
    J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states.
    McReynolds S; Jiang S; Rong L; Caffrey M
    J Magn Reson; 2009 Dec; 201(2):218-21. PubMed ID: 19819173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.
    Xu Y; Zhu J; Liu Y; Lou Z; Yuan F; Liu Y; Cole DK; Ni L; Su N; Qin L; Li X; Bai Z; Bell JI; Pang H; Tien P; Gao GF; Rao Z
    Biochemistry; 2004 Nov; 43(44):14064-71. PubMed ID: 15518555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
    Yuan K; Yi L; Chen J; Qu X; Qing T; Rao X; Jiang P; Hu J; Xiong Z; Nie Y; Shi X; Wang W; Ling C; Yin X; Fan K; Lai L; Ding M; Deng H
    Biochem Biophys Res Commun; 2004 Jul; 319(3):746-52. PubMed ID: 15184046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
    Matthews JM; Young TF; Tucker SP; Mackay JP
    J Virol; 2000 Jul; 74(13):5911-20. PubMed ID: 10846072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation.
    Celigoy J; McReynolds S; Caffrey M
    Biochem Biophys Res Commun; 2011 Sep; 412(3):483-6. PubMed ID: 21835164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design.
    Aydin H; Al-Khooly D; Lee JE
    Protein Sci; 2014 May; 23(5):603-17. PubMed ID: 24519901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
    Liu IJ; Kao CL; Hsieh SC; Wey MT; Kan LS; Wang WK
    Antiviral Res; 2009 Jan; 81(1):82-7. PubMed ID: 18983873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.
    Ingallinella P; Bianchi E; Finotto M; Cantoni G; Eckert DM; Supekar VM; Bruckmann C; Carfi A; Pessi A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8709-14. PubMed ID: 15161975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.
    Chan WE; Chuang CK; Yeh SH; Chang MS; Chen SS
    J Virol; 2006 Apr; 80(7):3225-37. PubMed ID: 16537590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
    Supekar VM; Bruckmann C; Ingallinella P; Bianchi E; Pessi A; CarfĂ­ A
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):17958-63. PubMed ID: 15604146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
    Song W; Gui M; Wang X; Xiang Y
    PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
    Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
    Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein.
    Duquerroy S; Vigouroux A; Rottier PJ; Rey FA; Bosch BJ
    Virology; 2005 May; 335(2):276-85. PubMed ID: 15840526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.